美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件: 药品名称=LIDOCAINE HYDROCHLORIDE
符合检索条件的记录共140
14 页 当前第 1 页  下一页 最后一页 返回检索页
1药品名称LIDOCAINE HYDROCHLORIDE
申请号017508产品号001
活性成分LIDOCAINE HYDROCHLORIDE市场状态停止上市
剂型或给药途径INJECTABLE;INJECTION规格2%
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构ABRAXIS PHARMACEUTICAL PRODUCTS
2药品名称LIDOCAINE HYDROCHLORIDE
申请号017508产品号002
活性成分LIDOCAINE HYDROCHLORIDE市场状态停止上市
剂型或给药途径INJECTABLE;INJECTION规格4%
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构ABRAXIS PHARMACEUTICAL PRODUCTS
3药品名称LIDOCAINE HYDROCHLORIDE
申请号017508产品号004
活性成分LIDOCAINE HYDROCHLORIDE市场状态停止上市
剂型或给药途径INJECTABLE;INJECTION规格20%
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构ABRAXIS PHARMACEUTICAL PRODUCTS
4药品名称LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE
申请号017584产品号001
活性成分LIDOCAINE HYDROCHLORIDE市场状态处方药
剂型或给药途径INJECTABLE;INJECTION规格2%
治疗等效代码AP参比药物
批准日期Approved Prior to Jan 1, 1982申请机构FRESENIUS KABI USA LLC
5药品名称LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE
申请号017584产品号002
活性成分LIDOCAINE HYDROCHLORIDE市场状态处方药
剂型或给药途径INJECTABLE;INJECTION规格4%
治疗等效代码AP参比药物
批准日期Approved Prior to Jan 1, 1982申请机构FRESENIUS KABI USA LLC
6药品名称LIDOCAINE HYDROCHLORIDE
申请号017701产品号001
活性成分LIDOCAINE HYDROCHLORIDE市场状态停止上市
剂型或给药途径INJECTABLE;INJECTION规格2%
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构INTERNATIONAL MEDICATION SYSTEMS LTD
7药品名称LIDOCAINE HYDROCHLORIDE
申请号017701产品号002
活性成分LIDOCAINE HYDROCHLORIDE市场状态停止上市
剂型或给药途径INJECTABLE;INJECTION规格1%
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构INTERNATIONAL MEDICATION SYSTEMS LTD
8药品名称LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE
申请号017702产品号001
活性成分LIDOCAINE HYDROCHLORIDE市场状态处方药
剂型或给药途径INJECTABLE;INJECTION规格20%
治疗等效代码AP参比药物
批准日期Approved Prior to Jan 1, 1982申请机构INTERNATIONAL MEDICATION SYSTEM
9药品名称LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE
申请号017702产品号002
活性成分LIDOCAINE HYDROCHLORIDE市场状态停止上市
剂型或给药途径INJECTABLE;INJECTION规格4%
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构INTERNATIONAL MEDICATION SYSTEM
10药品名称LIDOCAINE HYDROCHLORIDE 0.2% IN DEXTROSE 5% IN PLASTIC CONTAINER
申请号018388产品号001
活性成分LIDOCAINE HYDROCHLORIDE市场状态停止上市
剂型或给药途径INJECTABLE;INJECTION规格200MG/100ML
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构HOSPIRA INC